Atlas Trials

Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients

Clinical trial NCT02205164 · UNKNOWN

Trial details

NCT number
NCT02205164
Sponsor
Associazione Salentina Angela Serra
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy Induced Nausea and Vomiting
Start date
2011-10-01
Primary completion
2014-08-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.